Macrogenics (MGNX) Current Leases (2019 - 2026)
Macrogenics (MGNX) reported Current Leases of $5.2 million for Q1 2026, down 2.85% year-over-year from $5.4 million in Q1 2025, and up 0.71% quarter-over-quarter from $5.2 million in Q4 2025.
Macrogenics (MGNX) Current Leases (2019 - 2026) Analysis & Trends
Macrogenics (MGNX) has 8 years of Current Leases data on file, last reported at $5.2 million in Q1 2026.
- Current Leases for Q1 2026 came in at $5.2 million, down 2.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.2 million (down 2.85% YoY), and the FY2025 annual result was $5.2 million, up 6.44% from the prior year.
- Current Leases climbed to $5.2 million in Q1 2026 per MGNX's latest filing, from $5.2 million in the prior quarter.
- Over five years, Current Leases peaked at $5.4 million in Q1 2025 and troughed at $3.8 million in Q4 2023.
- A 5-year average of $4.7 million and a median of $4.8 million in 2022 frame the typical range for Current Leases.
- The sharpest annual moves came in 2023 and 2025: Current Leases decreased 21.81% in 2023, then jumped 31.38% in 2025.
- A 5-year view of Current Leases shows it stood at $4.7 million in 2022, then fell by 20.12% to $3.8 million in 2023, then gained by 28.85% to $4.9 million in 2024, then advanced by 6.44% to $5.2 million in 2025, then climbed by 0.71% to $5.2 million in 2026.
- Business Quant data shows MGNX's Current Leases at $5.2 million in Q1 2026, $5.2 million in Q4 2025, and $5.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Macrogenics | 260.14 Mn | 193.63 Mn | - | 5.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.21 Mn |
| Dec 31, 2025 | 5.18 Mn |
| Sep 30, 2025 | 5.14 Mn |
| Jun 30, 2025 | 5.12 Mn |
| Mar 31, 2025 | 5.37 Mn |
| Dec 31, 2024 | 4.86 Mn |
| Sep 30, 2024 | 4.74 Mn |
| Jun 30, 2024 | 4.41 Mn |
| Mar 31, 2024 | 4.09 Mn |
| Dec 31, 2023 | 3.78 Mn |
| Sep 30, 2023 | 3.93 Mn |
| Jun 30, 2023 | 4.16 Mn |
| Mar 31, 2023 | 4.42 Mn |
| Dec 31, 2022 | 4.73 Mn |
| Sep 30, 2022 | 5.02 Mn |
| Jun 30, 2022 | 4.94 Mn |
| Mar 31, 2022 | 4.84 Mn |
| Dec 31, 2021 | 4.68 Mn |
| Sep 30, 2021 | 4.52 Mn |
| Jun 30, 2021 | 4.37 Mn |